These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 16505408)

  • 1. Functional analysis of the breast cancer genome.
    Ellis MJ
    J Clin Oncol; 2006 Apr; 24(11):1649-50. PubMed ID: 16505408
    [No Abstract]   [Full Text] [Related]  

  • 2. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of gene-expression profiling to better understand the clinical heterogeneity of estrogen receptor positive breast cancers and tamoxifen response.
    Loi S; Piccart M; Sotiriou C
    Crit Rev Oncol Hematol; 2007 Mar; 61(3):187-94. PubMed ID: 17088071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.
    Oh DS; Troester MA; Usary J; Hu Z; He X; Fan C; Wu J; Carey LA; Perou CM
    J Clin Oncol; 2006 Apr; 24(11):1656-64. PubMed ID: 16505416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
    Yu K; Ganesan K; Miller LD; Tan P
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3288-96. PubMed ID: 16740749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer, estrogen receptor and ligands.
    Bai Z; Gust R
    Arch Pharm (Weinheim); 2009 Mar; 342(3):133-49. PubMed ID: 19274700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New generation of molecular prognostic and predictive tests for breast cancer.
    Pusztai L; Cristofanilli M; Paik S
    Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advantages of multiple clinical tests for determining the optimum treatment strategy for ER-positive breast cancer.
    Ditzel HJ; Lyng MB
    Nat Clin Pract Oncol; 2008 Jul; 5(7):376-7. PubMed ID: 18506164
    [No Abstract]   [Full Text] [Related]  

  • 9. [Alterations in the gene expression in tumors (author's transl)].
    Gamulin S
    Lijec Vjesn; 1981; 103(4-5):201-3. PubMed ID: 7321740
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells.
    Scafoglio C; Ambrosino C; Cicatiello L; Altucci L; Ardovino M; Bontempo P; Medici N; Molinari AM; Nebbioso A; Facchiano A; Calogero RA; Elkon R; Menini N; Ponzone R; Biglia N; Sismondi P; De Bortoli M; Weisz A
    J Cell Biochem; 2006 Aug; 98(5):1163-84. PubMed ID: 16514628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification of breast cancer: limitations and potential.
    Pusztai L; Mazouni C; Anderson K; Wu Y; Symmans WF
    Oncologist; 2006 Sep; 11(8):868-77. PubMed ID: 16951390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
    Calabrò A; Beissbarth T; Kuner R; Stojanov M; Benner A; Asslaber M; Ploner F; Zatloukal K; Samonigg H; Poustka A; Sültmann H
    Breast Cancer Res Treat; 2009 Jul; 116(1):69-77. PubMed ID: 18592372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
    Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
    Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving outcomes for patients with hormone receptor-positive breast cancer: back to the drawing board.
    Ellis MJ
    J Natl Cancer Inst; 2008 Feb; 100(3):159-61. PubMed ID: 18230793
    [No Abstract]   [Full Text] [Related]  

  • 16. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems and solutions in the evaluation of hormone receptors in breast cancer.
    Allred DC
    J Clin Oncol; 2008 May; 26(15):2433-5. PubMed ID: 18487563
    [No Abstract]   [Full Text] [Related]  

  • 18. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer in young women: a new color or a different shade of pink?
    Peppercorn J; Partridge AH
    J Clin Oncol; 2008 Jul; 26(20):3303-5. PubMed ID: 18612146
    [No Abstract]   [Full Text] [Related]  

  • 20. Whole-genome amplification of oral rinse self-collected DNA in a population-based case-control study of breast cancer.
    Liang X; Trentham-Dietz A; Titus-Ernstoff L; Newcomb PA; Welch RA; Hutchinson AA; Hampton JM; Sutcliffe CB; Haines JL; Egan KM
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1610-4. PubMed ID: 17684135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.